RxDoctor Payments Data

Lawrence Semel, MD

Vascular Surgery · Syracuse, NYNPI 1861561953

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,677 of the $2,085 with a category attached, or 80.4%. 14 manufacturers reported payments, led by Medtronic at 47.9% of the total. Reporting peaked in 2024 at $707 and has fallen 83.1% since, to $119 in 2025. That places this record below the midpoint for vascular surgery clinicians in NY, where the typical reported total is $4,841.

$2,085in general payments, 2019–2025

Across 57 payments — averaging $36.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$999
  • W. L. Gore & Associates, Inc.$497
  • Inari Medical, Inc.$258
  • Lemaitre Vascular, Inc.$69
  • Philips North America LLC$55
  • Boston Scientific$36
  • plus $171 from 8 others

What the payments were for

  • Travel & lodging$40820%
  • Food & beverage$1,67780%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,085 in reported general payments places this provider in the 30th percentile of 405 vascular surgery providers in New York.

See all vascular surgery providers in New York →

Medicare billing

Part B allowed, 2024
$436,434
Medicare patients
1,121
Services billed
2,407

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular surgery in Syracuse

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →